Med Tech Icon

Explore the strategic advantages of Ontario as the ideal location for Contract Development Manufacturing Organizations (CDMOs) and pharmaceutical companies. With a rich heritage of manufacturing excellence and access to top talent and world-class research partners, Ontario empowers you to develop and produce groundbreaking molecules at scale. Foster the future of pharmaceutical manufacturing right here in Ontario, where your ambitions can thrive.

A measurable difference


in pharmaceuticals revenue in 2022


of Canadian pharmaceutical employment


in goods exports


of Canada’s total pharmaceutical firms


of the world’s top pharmaceutical companies by revenue are conducting clinical trials in Ontario


people employed in pharma


invested in R & D

Pills being manufactured

Optimize growth in Competitive Business Environment

Maximize your potential in Ontario's high-quality pharmaceutical manufacturing sector, offering a competitive business environment tailored for end-to-end drug development and manufacturing operations. Take advantage of Ontario’s generous R&D tax credits which significantly reduce the after-tax cost of R&D expenditures, making it more cost-effective for large manufacturers and SMEs to innovate. Witness groundbreaking investments like OmniaBio’s $580+ million in a new biomanufacturing facility in Brampton, providing unparalleled opportunities for your company to thrive in the dynamic landscape of pharmaceutical innovation.

Financial Services icon, showing a coin with up and down arrows.


of Canada’s pharma revenue in 2022

Clock Icon

200 million 

people within 2 hours flight from Toronto

Toronto skyline during the day

Leverage Ontario's Strategic Location

Expand your CDMO business by partnering with a global clientele from Ontario. Benefit from access to top pharmaceutical companies and biotech startups and tap into major North American markets with  194+ million consumers within a day’s drive of the Greater Toronto Area. Take advantage of preferential access to global markets through 50+ trade agreements for efficient distribution of your pharmaceutical products manufactured in Ontario.

Pharmaceutical team meeting

Exceptional Talent and Ecosystem

Unlock Ontario's pharmaceutical potential by harnessing its robust life sciences ecosystem. Benefit from top-tier talent and R&D support from world-leading academic and research institutions. Ontario hosts world-renowned research centres, hospitals and clinics such as the Ontario Cancer Institute, SickKids, Mount Sinai and the London Health Sciences Centre offering invaluable resources in areas cancer research, regenerative medicine, diagnostic imaging, and neuroscience. Collaborate with CDMOs to accelerate drug development through strategic partnerships, ensuring efficient progress towards your goals.

quote mark

OmniaBio Inc. will be a game-changer for Ontario and Canada. It will provide missing infrastructure to allow Ontario and Canadian cell and gene companies to remain here, while also attracting foreign companies. Cell and gene therapy is Canada’s opportunity to be global leaders in life sciences. Investing in manufacturing is a key driver, and we’re grateful to Invest Ontario for its leadership and foresight.

Michael May

Chair, OmniaBio Inc.

In good company


Invest Ontario is supporting OmniaBio Inc. in launching a new biomanufacturing facility that will catalyze Ontario life sciences jobs and innovation while advancing pioneering medicine with the potential to cure, not just treat, many forms of cancers, cardiovascular diseases, Parkinson’s and diabetes.

CDMO & Pharma In Action In Ontario

Ontario welcomes announcement of investment from AstraZeneca to advance the fight against cancer
Ontario congratulates AstraZeneca on investment in Ontario to advance the fight against cancer and rare diseases

Discover Ontario’s growing life sciences sector with AstraZeneca’s announcement of investment in clinical trials bringing 500 new jobs in Peel and the surrounding region.

A researcher doing testing in a lab
Unleashing Innovation and Collaboration: Ontario, Canada’s Life Sciences Sector Leads the Way

Senior Economic Officers Aaron Pinto and Chelsea Peet discuss Ontario’s key life sciences value propositions and what makes the province a leader in the sector.

Architectural rendering of the OmniaBio facility at Hamilton’s McMaster Innovation Park
Invest Ontario supports new biomanufacturing facility in Hamilton

Invest Ontario supports new biomanufacturing facility in Hamilton, Canada. Project with OmniaBio Inc. drives global leadership in cell and gene therapy.

The flags of India and Canada side by side
Ontario attracts economic opportunities with Trade Mission to India

The Ontario government has concluded a successful trade mission to India to strengthen relationships with economic partners and attract new investments in key sectors.

Ontario booth at the BIO International Convention
Ontario promotes growing life sciences sector during Trade Mission to Boston

Invest Ontario was at BIO 2023 to promote the province’s growing life sciences and biotech sector and explore new opportunities for investment.

Invest Ontario. Here to help.

The RX For Growth Begins with a Conversation